Year: 2026
Key Financial Developments 2025Revenues of €180.0 million, down 1% yoy (2024: €181.9 million), with improved momentum in H2
Gross margin improved to 51.3% (2024: 50.9%), due to an improved product mix, higher operational efficiency, and centralized material purchasing strategy
Operational EBITDA increased to €21.1 million in 2025 (2024: €20.5 million), an EBITDA margin of 11.7% (2024: 11.3%)
Net loss improved to €-7.4 million (2024: €-9.4 million) supported by SHIFT plan execution, which reduced the personnel and operational expenses by €3 million year over year
Net working capital at €28.3 million or 15.7% of sales (2024: €26.7 million or 14.7% of sales)
Net debt decreased to €62.6 million (2024: €71.8 million). Net debt/EBITDA year end 2025 decreased to 2.7x from 3.2x (year-end 2024)
Total CAPEX materially reduced to €11.7 million...
Fiscal year 2025: RENK Group AG achieves annual targets with new record revenue and order backlog
Written by Customer Service on . Posted in Public Companies.
Fiscal year 2025: RENK Group AG achieves annual targets with new record revenue and order backlogRecord revenue of €1.37 billion (+19.8% year on year), fueled by strong growth in the defense business (+24.0% year on year)
Adjusted EBIT of €230 million (+21.7% year on year) at upper end of forecast range with improved margin of 16.9% (+0.3 percentage points year on year)
New record order intake of €1.57 billion underscores consistently high demand for RENK Group AG’s mission-critical propulsion solutions
Total order backlog reaches new all-time high of €6.68 billion (2024: €4,96 billion)
Proposed dividend of €0.58 per share – an increase of 38% compared to the previous year
Outlook: Further increase in revenue to over €1.5 billion and adjusted EBIT of between €255 million and €285 million currently expected for fiscal year 2026Augsburg,...
BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call
Written by Customer Service on . Posted in Public Companies.
BASEL, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) — BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multidrug-resistant (MDR) bacteria, announced today the reporting of its Full Year 2025 financial results, along with a business update and the hosting of an investor, analyst and media conference call.
The company will publish its Full Year 2025 financial results on March 18, 2026. On the reporting date, BioVersys will issue a press release at 7:00 AM CET / 2:00 AM ET.
Following the release, BioVersys will host a conference call and webcast on March 18, 2026 at 2:00 PM CET / 9:00 AM ET where management will review the financial results, provide a business update, outline its strategic...
WISeKey Reports FY 2025 Preliminary Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
WISeKey Reports FY 2025 Preliminary Financial Results
Subsidiary SEALSQ Delivers 66% Year-Over-Year Revenue Growth and Advances Global Quantum-Secure Semiconductor Ecosystem
Geneva, Switzerland, March 5, 2026 – Ad hoc announcement pursuant to Art. 53 LR – WISeKey International Holding Ltd (“WISeKey” or “WISeKey Group”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today reported key operational and financial metrics for the fourth quarter (“Q4”) and full year (“FY”) ended December 31, 2025.
These figures include preliminary results from its subsidiary, SEALSQ Corp (NASDAQ: LAES) (“SEALSQ”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products. WISeKey holds 52% of the voting rights in SEALSQ, enabling...
Dave Announces Pricing of $175 Million 0% Convertible Notes
Written by Customer Service on . Posted in Public Companies.
Company entered into capped call transactions to increase effective conversion premium to 100%
Company to repurchase approximately 334,000 shares of common stock using approximately $70.5 million of net proceeds
Los Angeles, March 05, 2026 (GLOBE NEWSWIRE) — Dave Inc. (Nasdaq: DAVE) (“Dave” or the “Company”) today announced the pricing of an offering of $175 million principal amount of its 0% Convertible Senior Notes due 2031 (the “notes”) through a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Dave has also granted the initial purchasers an option to purchase, for settlement within a 13-day period beginning on, and including, the date Dave first issues the notes, up to an additional $25 million principal...
Amplify Energy Delays Fourth Quarter 2025 Earnings Release
Written by Customer Service on . Posted in Public Companies.
HOUSTON, March 04, 2026 (GLOBE NEWSWIRE) — Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that it will delay the issuance of its fourth quarter and full year 2025 earnings release previously scheduled for March 5, 2026. The delay in the release of earnings is required primarily to allow additional time to finalize certain accounting treatments related to the divestiture of assets. The earnings release is now expected to be issued after the U.S. financial markets close on March 9, 2026.
About Amplify Energy
Amplify Energy Corp. is an independent oil company engaged in the acquisition, development, exploitation and production of oil properties. Amplify’s operations are focused in federal waters offshore Southern California (Beta) and the Rockies (Bairoil). For more information, visit www.amplifyenergy.com.
Investor...
LGI Homes, Inc. Reports February 2026 Home Closings
Written by Customer Service on . Posted in Public Companies.
THE WOODLANDS, Texas, March 04, 2026 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 247 homes in February 2026, which includes the closing of 10 currently or previously leased single-family rental homes.
As of February 28, 2026, the Company had 140 active selling communities.
About LGI Homes, Inc.
Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. LGI Homes has closed over 80,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was named to Newsweek’s list of the World’s Most Trustworthy...
Athabasca Oil Announces 2025 Year-end Results and Reserves
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
CALGARY, Alberta, March 04, 2026 (GLOBE NEWSWIRE) — Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) is pleased to report its audited 2025 year-end results and reserves. The annual results are highlighted by strong operational performance across all assets, resilient financial performance, and execution of continued shareholder returns. Athabasca provides investors unique positioning to top tier liquids weighted assets (Thermal Oil and Duvernay) with a focus on maximizing cash flow per share growth by investing in competitive projects alongside a return of capital framework focused on share buybacks.
Year-end 2025 Consolidated Corporate ResultsProduction: Average annual production of 39,375 boe/d (98% Liquids), representing 7% (17% per share) growth year-over-year. Strong performance across all assets supported...
Medline Inc. announces pricing of secondary offering of class A common stock
Written by Customer Service on . Posted in Public Companies.
NORTHFIELD, Ill., March 04, 2026 (GLOBE NEWSWIRE) — Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of a previously announced secondary offering of 75,000,000 shares of Medline Inc.’s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) at a price to the public of $41.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline’s Class A common stock. The offering is expected to close on March 10, 2026, subject to customary closing conditions.
Medline is not selling any shares of Class A common stock in the offering and will not receive any...
Blue Hat Announces an Updated Effective Time for 1-for-50 Reverse Stock Split
Written by Customer Service on . Posted in Public Companies.
XIAMEN, China, March 04, 2026 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), a Cayman Islands exempted company, previously reported on March 3, 2026 that it expects to implement a 1-for-50 reverse stock split on its ordinary shares (the “Reverse Stock Split”) effective Friday, March 6, 2026, with trading to begin on a split-adjusted basis at the market open on that day. Such time will now be postponed to Monday, March 9, 2026, with trading to begin on a split-adjusted basis at the market open on that day. Before such reverse stock split, as of March 3, 2026, the Company has a total of 154,912,000 ordinary shares, par value $0.0000001 per share issued and outstanding. Trading in the ordinary shares is expected to continue on the Nasdaq Capital Market under the symbol...
